Results 241 to 250 of about 82,694 (258)

Membranous nephropathy

Nature Reviews Disease Primers, 2021
Pierre Ronco, Hanna Debiec, Fernando C Fervenza   +2 more
exaly  

Acetylcysteine for prevention of contrast nephropathy: meta-analysis

Lancet, The, 2003
Florian Markowetz
exaly  

Pathogenesis, prevention, and treatment of diabetic nephropathy

Lancet, The, 1998
Mark E Cooper
exaly  

Corticosteroids in IgA nephropathy: a randomised controlled trial

Lancet, The, 1999
Simeone Andrulli, Claudio Ponticelli
exaly  

Urothelial malignant disease and Chinese herbal nephropathy

Lancet, The, 2001
Volker M. Arlt
exaly  

Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy

Nature Reviews Nephrology, 2011
Juan F Navarro-González, Carmen Mora-Fernández, Javier García-Orza   +2 more
exaly  

Immunosuppression for progressive membranous nephropathy: a UK randomised controlled trial

Lancet, The, 2013
Dwomoa Adu
exaly  

Rituximab for idiopathic membranous nephropathy

Lancet, The, 2002
Giuseppe Remuzzi
exaly  

Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial

Lancet, The, 2017
Jonathan Barratt, Rosanna Coppo, Johan W De Fijter   +2 more
exaly  

Medical versus surgical treatment in children with severe bilateral vesicoureteric reflux and bilateral nephropathy: a randomised trial

Lancet, The, 2001
Adrian S Woolf
exaly